SynAbs inks agreement with Dianova GmbH as new distributor for its unique catalogue of monoclonal antibodies in Germany

 13 Jan 2017


SynAbs is proud to announce strategic deal with successful company Dianova. Dianova has already demonstrated a huge knowledge and expertise in monoclonal antibodies and will consequently extend its catalogue with unique mAbs references from SynAbs. Under the terms of the agreement, Dianova will have access to unique portfolio of rats and guinea pigs mAbs to address German territory needs in R&D and IVD fields.


Kristine Fischer - Director Business Development dianova GmbH

Warburgstrasse 45

20354 Hamburg


Phone: +49 40 45 06 78 10 - Fax: +49 40 45 06 74 90

SynAbs appoints LuBioScience GmbH as new distributor for its unique catalogue of monoclonal antibodies in Switzerland

SynAbs is proud to appoint LuBioSience as its new distributor for Switzerland. LuBioScience has a seasoned team and expertise in selling biochemicals, including the specific monoclonal antibodies of SynAbs, in particular the anti-species which should be welcomed by the Swiss Biopharma R&D and IVD sector.


Roland Schärli - CEO LuBioScience GmbH

Töpferstrasse 5

PO Box

6004 Lucerne


Phone: +41 41 417 02 80 - Fax: +41 41 417 02 89

Guinea pig monoclonal antibodies : a new promising tool for R&D, IVD and therapeutics

Monoclonal antibodies development has been limited for a long time to only two species : mice and rats. However, the immune systems of mice and rats are not the most suitable in terms of humoral response to certain antigens, such as human antigens like glucagon. Indeed, the protein sequence of glucagon is the same in mice, rats and human (fig. 1). Small not immunogenic antigens, such as antibiotics or toxins, generally failed to trigger an immune response in such species. This is why some companies have developed fusion cell lines to

generate monoclonal antibodies in rabbit (Abcam-Epitomics) or in sheep (Bioventix). However, these two tools are not totally satisfactory whether in terms of cost, stability or productivity.

SynAbs has therefore opted to develop its own myeloma cell line to manufacture guinea pig monoclonal antibodies and offer more efficient investigation tools for researchers.

read more

Our Antibody products

SynAbs proposes a catalog of more than 100 rat and mice monoclonal antibodies.

>> to see our catalog


Custom Antibody Services

SynAbs maximizes the success rate and the quality of the mAbs generated in rats and mice. >> more about our technology


The Rat mAbs  experts

SynAbs is a dedicated Monoclonal Antibody Manufacturing Center.

>> read more about our expertise

The benefits of our technology?

  1. Higher specificity
  2. Higher affinity
  3. Excellent results, even for small and difficult antigens
  4. Additional epitope recognition
  5. Access to the lymph nodes
  6. Rat Fc close to the human one
  7. Ideal for mice antigens

Our agenda

When ?

Feb 2nd - Feb 3rd

Feb 16th

April 3rd - April 5th

May 9th - May 10th

May 18th

May 23rd - May 25th

June 21st

July 30th - August 3rd

October 17th

Nov 11th - Nov 16th














Where ?

Evry, France, Buzz4Bio Bioproduction

Rotterdam, The Netherlands, Innovation for Health

Singapour, Singapour, Medlab

Eindhoven, The Netherlands, Biomedica

Ghent, Belgium, Knowledge 4 Growth

Tel Aviv, Israël, BioMed

Oxford, United Kingdom, Pivotal Scientific

San Diego, USA, AACC

Yokohama, Japan, BioJapan

Dusseldorf, Germany, Medica